MAP2K1 and neoplasm: We found that compared to MEK1‐low tumours, MEK1‐hi tumours had a 15% increase in the relative frequency of CD45+ cells (p < 0.05), a 95% increase in CD8+ T cells (p = 0.075), and a 100% increase in NK cells (p < 0.05).